Margetuximab: An active alternative for later-line therapy in patients with HER2-positive advanced breast cancer

被引：1
|
作者：
Zhou, Yunxiang [1 ,2 ]
Wang, Xiaojia [3 ]
Chen, Yiding [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Breast Surg & Oncol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Canc Inst,Key Lab Canc Prevent & Intervent,China N, Hangzhou, Zhejiang, Peoples R China
[3] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC, Dept Breast Med Oncol,Canc Hosp,Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
MEDCOMM | 2023年 / 4卷 / 04期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/mco2.322
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Lapatinib: clinical benefit in patients with HER2-positive advanced breast cancer
    Kroep, J. R.
    Linn, S. C.
    Boven, E.
    Bloemendal, H. J.
    Baas, J.
    Mandjes, I. A. M.
    van den Bosch, J.
    Smit, W. M.
    de Graaf, H.
    Schroder, C. P.
    Vermeulen, G. J.
    Hop, W. C. J.
    Nortier, J. W. R.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (09): : 371 - 376
  • [22] Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapy
    Li, Jiaping
    Lu, Qianyi
    Zhou, Hanxing
    Xu, Fei
    Huang, Jiajia
    Hong, Ruoxi
    Wang, Shusen
    ANTI-CANCER DRUGS, 2023, 34 (07) : 892 - 895
  • [23] Expanding the role of systemic therapy for patients with active, HER2-positive breast cancer brain metastases
    Lin, N. U.
    ESMO OPEN, 2022, 7 (06)
  • [24] Systemic Therapies for HER2-Positive Advanced Breast Cancer
    Angelis, Vasileios
    Okines, Alicia F. C.
    CANCERS, 2024, 16 (01)
  • [25] Two Drugs for Advanced HER2-Positive Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1611): : 182 - 184
  • [26] HER2-positive advanced breast cancer treatment in 2020
    Cesca, Marcelle G.
    Vian, Lucas
    Cristovao-Ferreira, Sofia
    Ponde, Noam
    de Azambuja, Evandro
    CANCER TREATMENT REVIEWS, 2020, 88
  • [27] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [28] Margetuximab Anti-HER2 monoclonal antibody Treatment of metastatic HER2-positive breast cancer Treatment of HER2-positive gastric or gastroeso-phageal junction cancer
    Hanna, K. S.
    DRUGS OF THE FUTURE, 2021, 46 (03) : 191 - 195
  • [29] Hormonotherapy in patients with HER2-positive breast cancer
    Debska, Sylwia
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (06): : 301 - 310
  • [30] Cardiotoxicity in HER2-positive breast cancer patients
    Gonciar, Diana
    Mocan, Lucian
    Zlibut, Alexandru
    Mocan, Teodora
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (04) : 919 - 935
12345